FDA inspection
Sanofi S.r.l.: FDA inspection ending May 22, 2023
FDA inspection 1219964 · Voluntary Action Indicated (VAI) · Anagni
Key facts
| Inspection ID | 1219964 |
|---|---|
| Firm | Sanofi S.r.l. |
| FEI number | 3002807108 |
| Address | Via Valcanello 4 |
| City | Anagni |
| Fiscal year | 2023 |
| Inspection end date | May 22, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data